Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03052166 · ClinicalTrials.gov registry record
Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging
A clinical trial, sponsored by QT Ultrasound.
- Completed
- Registry status
- 755
- Enrollment target
NCT03052166 is a clinical trial that has completed, run by QT Ultrasound. The registered enrollment target is 755 participants.
The verdict
NCT03052166 has completed, sponsored by QT Ultrasound.
- COMPLETED
- Registry status
- 755 participants
- Enrollment target
Study Summary
Brief Summary: The QT Ultrasound system is an automated scanner which transmits pulsed ultrasound plane waves through the breast, as well as collects reflected ultrasound output. As the patient lays prone on a table, the breast is submerged in a warm water bath. The transmitter and receiver assembly moves around the suspended breast to record data for successive sub-volumes of targeted tissue. More than 2000 elements in the curvilinear transducer's array encircle the breast to gather data from the tissue structures of the breast, from nipple to chest wall. Information gathered from this automated QT scan encompasses the entire breast which is currently not commercially available using any other ultrasound technology.
Interventions
- DEVICE QT Ultrasound scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 755 participants |
| Start Date | 2017-04-18 |
| Est. Completion | 2020-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03052166
The ClinicalTrials.gov registry entry for NCT03052166 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 755 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is QT Ultrasound, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which QT Ultrasound scan is the first listed.
NCT03052166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03052166 about?
NCT03052166 is a clinical study titled "Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging". Brief Summary: The QT Ultrasound system is an automated scanner which transmits pulsed ultrasound plane waves through the breast, as well as collects reflected ultrasound output. As the patient lays prone on a table, the breast is submerged in a warm water bath. The transmitter and receiver assembly...
What is the current status of trial NCT03052166?
This trial is currently completed. The enrollment target is 755 participants. The study started on 2017-04-18. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT03052166?
The interventions under investigation include: QT Ultrasound scan (DEVICE).
Who is sponsoring clinical trial NCT03052166?
This trial is sponsored by QT Ultrasound, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.